Prosecutors: Reveal Rajaratnam's Medical Problems

Sep 30 2011 | 11:40am ET

If Galleon Group founder Raj Rajaratnam is to get a break on his sentence for insider-trading due to his health problems, prosecutors say that the public has a right to know exactly what those problems are.

The U.S. Attorney's Office in Manhattan has asked U.S. District Judge Richard Holwell to unseal a number of letters and declarations dealing with Rajaratnam's medical conditions. The former billionaire's lawyers have repeatedly cited Rajaratnam's health—among other things—in decrying the "grostequely severe" sentence of between 19½ and 24½ years sought by prosecutors, going so far as to call it a death sentence. But they have never specified what precisely the "unique constellation of ailments ravaging" Rajaratnam's body are, although Rajaratnam had emergency foot surgery during his trial earlier this year.

"While individuals have a right to medical privacy, Rajaratnam waived such rights, at least in part, by arguing that his medical conditions justify departing or varying from the sentencing guidelines," prosecutors wrote. "The public has a First Amendment right to see the arguments and declarations that both parties submitted to this court about the impact of his medical condition on sentencing."

Prosecutors also called on Holwell to make public "the general nature of his medical conditions and his long-term prognosis" if he chooses to take Rajaratnam's health into account when he sentences the fraudster on Oct. 13.

Which is not to say that prosecutors are buying Rajaratnam's argument. They noted that Rajaratnam committed most of his crimes with full knowledge of his medical condition, and that other defendants in the case have not received leniency for serious medical issues. They also took issue with the defense's allegation that a long sentence for the 54-year-old would be a death sentence, arguing that the U.S. Bureau of Prisons can provide adequate medical care.

Rajaratnam's lawyers have not responded to the request to unseal.


In Depth

Kettera Q&A: The Advantages of Alternative Investment Platforms

Oct 28 2016 | 5:52pm ET

The past several years have seen a distinct push towards easier and cheaper access...

Lifestyle

Midtown's Plaza District Fades As Manhattan Office Landscape Shifts

Nov 22 2016 | 6:32pm ET

Lower leasing costs, more efficient office space and the hope of projecting an image...

Guest Contributor

Nowhere to Hide: Why the Future of Asset Management Depends on Innovation

Nov 15 2016 | 6:55pm ET

Information technology has reshaped the asset management industry’s periphery,...

 

From the current issue of

Chicago-based independent futures brokerage and clearing firm R.J. O’Brien & Associates (RJO) has hired industry veteran Daniel Staniford as Executive Director, responsible for the firm’s institutional business development in New York and London.

AVAILABLE NOW at BARNES & NOBLE

NEWSTAND LOCATOR